The efficacy of carbamazepine combinations in epilepsy

James Cereghino, Joseph T. Brock, John C. Van Meter, J. Kiffin Penry, Lawrence D. Smith, Billy G. White

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

The efficacy and bioavailability, and tolerance to carbamazepine when administered with phenobarbital or phenytoin or with both drugs were evaluated in a prospective, double-blind study of patients whose seizures were not completely controlled by currently available antiepileptic drugs in usually therapeutic dosages as determined by serum levels. During each of four 21-day treatment periods, one fourth of the patients received daily doses of.: (1) carbamazepine (1,200 mg) and phenytoin (300 mg); (2) carbamazepine (1,200 mg) and phenobarbital (300 mg); (3) phenytoin (300 mg) and phenobarbital (300 mg); or (4) carbamazepine (1,200 mg), with phenytoin (300 mg) and phenobarbital (300 mg). The treatment periods were separated by 2 wk of each patient's usual prestudy medication. Treatment with all three drugs was the most efficacious for seizure control. Serum carbamazepine concentration was significantly decreased when the drug was administered with either phenytoin or phenobarbital or both.

Original languageEnglish (US)
Pages (from-to)733-741
Number of pages9
JournalClinical Pharmacology and Therapeutics
Volume18
Issue number6
StatePublished - Dec 1975
Externally publishedYes

Fingerprint

Carbamazepine
Phenytoin
Phenobarbital
Epilepsy
Seizures
Pharmaceutical Preparations
Therapeutics
Serum
Double-Blind Method
Anticonvulsants
Biological Availability

ASJC Scopus subject areas

  • Pharmacology

Cite this

Cereghino, J., Brock, J. T., Van Meter, J. C., Penry, J. K., Smith, L. D., & White, B. G. (1975). The efficacy of carbamazepine combinations in epilepsy. Clinical Pharmacology and Therapeutics, 18(6), 733-741.

The efficacy of carbamazepine combinations in epilepsy. / Cereghino, James; Brock, Joseph T.; Van Meter, John C.; Penry, J. Kiffin; Smith, Lawrence D.; White, Billy G.

In: Clinical Pharmacology and Therapeutics, Vol. 18, No. 6, 12.1975, p. 733-741.

Research output: Contribution to journalArticle

Cereghino, J, Brock, JT, Van Meter, JC, Penry, JK, Smith, LD & White, BG 1975, 'The efficacy of carbamazepine combinations in epilepsy', Clinical Pharmacology and Therapeutics, vol. 18, no. 6, pp. 733-741.
Cereghino J, Brock JT, Van Meter JC, Penry JK, Smith LD, White BG. The efficacy of carbamazepine combinations in epilepsy. Clinical Pharmacology and Therapeutics. 1975 Dec;18(6):733-741.
Cereghino, James ; Brock, Joseph T. ; Van Meter, John C. ; Penry, J. Kiffin ; Smith, Lawrence D. ; White, Billy G. / The efficacy of carbamazepine combinations in epilepsy. In: Clinical Pharmacology and Therapeutics. 1975 ; Vol. 18, No. 6. pp. 733-741.
@article{f0f5bd19432a4d4a8f9a9c0e336bf680,
title = "The efficacy of carbamazepine combinations in epilepsy",
abstract = "The efficacy and bioavailability, and tolerance to carbamazepine when administered with phenobarbital or phenytoin or with both drugs were evaluated in a prospective, double-blind study of patients whose seizures were not completely controlled by currently available antiepileptic drugs in usually therapeutic dosages as determined by serum levels. During each of four 21-day treatment periods, one fourth of the patients received daily doses of.: (1) carbamazepine (1,200 mg) and phenytoin (300 mg); (2) carbamazepine (1,200 mg) and phenobarbital (300 mg); (3) phenytoin (300 mg) and phenobarbital (300 mg); or (4) carbamazepine (1,200 mg), with phenytoin (300 mg) and phenobarbital (300 mg). The treatment periods were separated by 2 wk of each patient's usual prestudy medication. Treatment with all three drugs was the most efficacious for seizure control. Serum carbamazepine concentration was significantly decreased when the drug was administered with either phenytoin or phenobarbital or both.",
author = "James Cereghino and Brock, {Joseph T.} and {Van Meter}, {John C.} and Penry, {J. Kiffin} and Smith, {Lawrence D.} and White, {Billy G.}",
year = "1975",
month = "12",
language = "English (US)",
volume = "18",
pages = "733--741",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - The efficacy of carbamazepine combinations in epilepsy

AU - Cereghino, James

AU - Brock, Joseph T.

AU - Van Meter, John C.

AU - Penry, J. Kiffin

AU - Smith, Lawrence D.

AU - White, Billy G.

PY - 1975/12

Y1 - 1975/12

N2 - The efficacy and bioavailability, and tolerance to carbamazepine when administered with phenobarbital or phenytoin or with both drugs were evaluated in a prospective, double-blind study of patients whose seizures were not completely controlled by currently available antiepileptic drugs in usually therapeutic dosages as determined by serum levels. During each of four 21-day treatment periods, one fourth of the patients received daily doses of.: (1) carbamazepine (1,200 mg) and phenytoin (300 mg); (2) carbamazepine (1,200 mg) and phenobarbital (300 mg); (3) phenytoin (300 mg) and phenobarbital (300 mg); or (4) carbamazepine (1,200 mg), with phenytoin (300 mg) and phenobarbital (300 mg). The treatment periods were separated by 2 wk of each patient's usual prestudy medication. Treatment with all three drugs was the most efficacious for seizure control. Serum carbamazepine concentration was significantly decreased when the drug was administered with either phenytoin or phenobarbital or both.

AB - The efficacy and bioavailability, and tolerance to carbamazepine when administered with phenobarbital or phenytoin or with both drugs were evaluated in a prospective, double-blind study of patients whose seizures were not completely controlled by currently available antiepileptic drugs in usually therapeutic dosages as determined by serum levels. During each of four 21-day treatment periods, one fourth of the patients received daily doses of.: (1) carbamazepine (1,200 mg) and phenytoin (300 mg); (2) carbamazepine (1,200 mg) and phenobarbital (300 mg); (3) phenytoin (300 mg) and phenobarbital (300 mg); or (4) carbamazepine (1,200 mg), with phenytoin (300 mg) and phenobarbital (300 mg). The treatment periods were separated by 2 wk of each patient's usual prestudy medication. Treatment with all three drugs was the most efficacious for seizure control. Serum carbamazepine concentration was significantly decreased when the drug was administered with either phenytoin or phenobarbital or both.

UR - http://www.scopus.com/inward/record.url?scp=0016594893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016594893&partnerID=8YFLogxK

M3 - Article

C2 - 1106934

AN - SCOPUS:0016594893

VL - 18

SP - 733

EP - 741

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 6

ER -